title: Weekly intermittent 2-CdA is less toxic and equally efficacious when compared to continuous infusion in hairy cell leukaemia.
authors.forename: J
authors.initials: J
authors.lastname: Chacko
authors.forename: C
authors.initials: C
authors.lastname: Murphy
authors.forename: C
authors.initials: C
authors.lastname: Duggan
authors.forename: D S
authors.initials: DS
authors.lastname: O'Briain
authors.forename: P V
authors.initials: PV
authors.lastname: Browne
authors.forename: S R
authors.initials: SR
authors.lastname: McCann
mesh_terms: D000328:Adult; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage*; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D017338:Cladribine / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D007943:Leukemia, Hairy Cell / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D015649:Pentostatin / Q000008:administration & dosage*
chemical_list: D000903:Antibiotics, Antineoplastic; D000970:Antineoplastic Agents; D015649:Pentostatin; D017338:Cladribine